Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA)

NCT02060162 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02060162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02060162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa: a Collaborative Multi-country Prospective Cohort Analysis for International Epidemiologic Databases to Evaluate AIDS- Southern Africa (HIV/HBV-coinfection in IeDEA-SA)
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
October 31, 2013
Completion date
January 1, 2021
Enrollment
897 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

africa, alcohol use disorder, antiretroviral therapy, hepatitis b virus, hiv, liver fibrosis